IBD98-M

· Holy Stone Healthcare Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBD98-M, covering 2015-04-22 to 2020-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M [Phase 2]